{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:01:30Z","timestamp":1793221290446,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["Cancer Prevention Fellowship Program"],"award-info":[{"award-number":["Cancer Prevention Fellowship Program"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"Georgia CTSA","doi-asserted-by":"crossref","award":["(UL 1TR002378)"],"award-info":[{"award-number":["(UL 1TR002378)"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016220","name":"Georgia CTSA","doi-asserted-by":"crossref","award":["(KL2TR002381)"],"award-info":[{"award-number":["(KL2TR002381)"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10552-020-01280-6","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T08:02:36Z","timestamp":1582617756000},"page":"309-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-7775","authenticated-orcid":false,"given":"Ronald C.","family":"Eldridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hartge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy J.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"issue":"6","key":"1280_CR1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX et al (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113(6):898\u2013918","journal-title":"Circulation"},{"key":"1280_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840","journal-title":"Nature"},{"issue":"2","key":"1280_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1467-789x.2001.00025.x","volume":"2","author":"A Mart\u00ed","year":"2001","unstructured":"Mart\u00ed A, Marcos A, Mart\u00ednez J (2001) Obesity and immune function relationships. Obes Rev 2(2):131\u2013140","journal-title":"Obes Rev"},{"issue":"4","key":"1280_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","volume":"17","author":"SA Ritchie","year":"2007","unstructured":"Ritchie SA, Connell JMC (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17(4):319\u2013326","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"1280_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579\u2013591","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1280_CR6","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531\u20131543","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1280_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/JOE-10-0072","volume":"206","author":"AE Wallace","year":"2010","unstructured":"Wallace AE, Gibson DA, Saunders PTK, Jabbour HN (2010) Inflammatory events in endometrial adenocarcinoma. J Endocrinol 206(2):141\u2013157","journal-title":"J Endocrinol"},{"issue":"2","key":"1280_CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/edrv-10-2-136","volume":"10","author":"ER Simpson","year":"1989","unstructured":"Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Mendelson CR (1989) Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev 10(2):136\u2013148","journal-title":"Endocr Rev"},{"issue":"9484","key":"1280_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491\u2013505","journal-title":"Lancet"},{"issue":"10","key":"1280_CR10","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","volume":"18","author":"RCM van Kruijsdijk","year":"2009","unstructured":"van Kruijsdijk RCM, van der Wall E, Visseren FLJ (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev 18(10):2569\u20132578","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1280_CR11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/aje\/kws357","volume":"177","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi AK, Moore SC, Hildesheim A (2013) Invited commentary: circulating inflammation markers and cancer risk\u2014implications for epidemiologic studies. Am J Epidemiol 177(1):14\u201319","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1280_CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/1354750X.2017.1306752","volume":"22","author":"RC Eldridge","year":"2017","unstructured":"Eldridge RC, Flanders WD, Bostick RM, Fedirko V, Gross M, Thyagarajan B et al (2017) Using multiple biomarkers and determinants to obtain a better measurement of oxidative stress: a latent variable structural equation model approach. Biomarkers 22(6):517\u2013524","journal-title":"Biomarkers"},{"issue":"12","key":"1280_CR13","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/1055-9965.EPI-05-0493","volume":"14","author":"F Modugno","year":"2005","unstructured":"Modugno F, Ness RB, Chen C, Weiss NS (2005) Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14(12):2840\u20132847","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"1280_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28(5):521\u2013574","journal-title":"Endocr Rev"},{"issue":"5","key":"1280_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1055-9965.EPI-10-1222","volume":"20","author":"T Wang","year":"2011","unstructured":"Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN et al (2011) A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev 20(5):971\u2013977","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1280_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1677\/ERC-10-0053","volume":"17","author":"L Dossus","year":"2010","unstructured":"Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A et al (2010) Obesity, inflammatory markers, and endometrial cancer risk: a prospective case\u2013control study. Endocr Relat Cancer 17(4):1007\u20131019","journal-title":"Endocr Relat Cancer"},{"issue":"7121","key":"1280_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444(7121):875\u2013880","journal-title":"Nature"},{"issue":"25","key":"1280_CR18","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1200\/JCO.2005.02.048","volume":"23","author":"PJ Goodwin","year":"2005","unstructured":"Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J et al (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23(25):6037\u20136042","journal-title":"J Clin Oncol"},{"issue":"1","key":"1280_CR19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25(1):4\u20137","journal-title":"Trends Immunol"},{"issue":"4","key":"1280_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.yfrne.2008.04.001","volume":"29","author":"E Vegeto","year":"2008","unstructured":"Vegeto E, Benedusi V, Maggi A (2008) Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 29(4):507\u2013519","journal-title":"Front Neuroendocrinol"},{"issue":"5","key":"1280_CR21","doi-asserted-by":"crossref","first-page":"R459","DOI":"10.1152\/ajpregu.00222.2013","volume":"305","author":"B Xue","year":"2013","unstructured":"Xue B, Johnson AK, Hay M (2013) Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol-Regul Integr Comp Physiol 305(5):R459\u2013R463","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"issue":"2","key":"1280_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MNH.0b013e3283431921","volume":"20","author":"X-P Yang","year":"2011","unstructured":"Yang X-P, Reckelhoff JF (2011) Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 20(2):133\u2013138","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1280_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1200\/EdBook_AM.2013.33.46","volume":"33","author":"NM Iyengar","year":"2013","unstructured":"Iyengar NM, Hudis CA, Dannenberg AJ (2013) Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ 33:46\u201351","journal-title":"Am Soc Clin Oncol Educ"},{"issue":"1","key":"1280_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-017-0810-0","volume":"19","author":"H Oh","year":"2017","unstructured":"Oh H, Coburn SB, Matthews CE, Falk RT, LeBlanc ES, Wactawski-Wende J et al (2017) Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Breast Cancer Res 19(1):28\u201328","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1280_CR25","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","volume":"21","author":"PC Prorok","year":"2000","unstructured":"Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, David Crawford E et al (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(6):273S\u2013309S","journal-title":"Control Clin Trials"},{"issue":"3","key":"1280_CR26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ijc.30478","volume":"140","author":"B Trabert","year":"2017","unstructured":"Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C et al (2017) Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Int J Cancer 140(3):600\u2013610","journal-title":"Int J Cancer"},{"issue":"8","key":"1280_CR27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0735-1097(03)00156-6","volume":"41","author":"W Vongpatanasin","year":"2003","unstructured":"Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I (2003) Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 41(8):1358\u20131363","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1280_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","volume":"100","author":"M Cushman","year":"1999","unstructured":"Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL et al (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins, the Postmenopausal Estrogen\/Progestin Interventions (PEPI) study. Circulation 100(7):717\u2013722","journal-title":"Circulation"},{"issue":"9","key":"1280_CR29","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1055-9965.EPI-11-0221","volume":"20","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S et al (2011) Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomark Prev 20(9):1902\u20131911","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1280_CR30","unstructured":"FAQ: How do I interpret a regression model when some variables are log transformed? UCLA: statistical consulting group; https:\/\/stats.idre.ucla.edu\/other\/mult-pkg\/faq\/general\/faqhow-do-i-interpret-a-regression-model-when-some-variables-are-log-transformed\/. Accessed 28 June 2018."},{"key":"1280_CR31","volume-title":"Base SAS 9.4 procedures guide","author":"SAS, Institute, Inc","year":"2012","unstructured":"SAS, Institute, Inc. (2012) Base SAS 9.4 Procedures Guide. 2nd. SAS Institute Inc., Cary"},{"issue":"10","key":"1280_CR32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-0528.2006.01004.x","volume":"113","author":"R Cancello","year":"2006","unstructured":"Cancello R, Cl\u00e9ment K (2006) Review article: is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113(10):1141\u20131147","journal-title":"BJOG"},{"issue":"3","key":"1280_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86(3):225\u2013230","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"1280_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","volume":"88","author":"N Potischman","year":"1996","unstructured":"Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88(11):756\u2013758","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1280_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-008-9212-z","volume":"20","author":"K Heikkila","year":"2009","unstructured":"Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J et al (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20(1):15\u201326","journal-title":"Cancer Causes Control"},{"issue":"8","key":"1280_CR36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/aje\/kws309","volume":"177","author":"L Dossus","year":"2013","unstructured":"Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S et al (2013) Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort: a factor analysis. Am J Epidemiol 177(8):787\u2013799","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1280_CR37","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspect Biol 6(10):a016295","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"3","key":"1280_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2796.2008.01946.x","volume":"264","author":"S St\u00f6rk","year":"2008","unstructured":"St\u00f6rk S, Bots ML, Grobbee DE, Van Der Schouw YT (2008) Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. J Intern Med 264(3):245\u2013253","journal-title":"J Intern Med"},{"issue":"12","key":"1280_CR39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10654-005-3657-0","volume":"20","author":"AR Folsom","year":"2005","unstructured":"Folsom AR, Golden SH, Boland LL, Szklo M (2005) Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. Eur J Epidemiol 20(12):1015\u20131022","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"1280_CR40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/jc.2010-1902","volume":"96","author":"M Maggio","year":"2011","unstructured":"Maggio M, Ceda GP, Lauretani F, Bandinelli S, Corsi AM, Giallauria F et al (2011) SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab 96(4):1053\u20131059","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1280_CR41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/jwh.2006.15.14","volume":"15","author":"C Crandall","year":"2006","unstructured":"Crandall C, Palla S, Reboussin B, Hu P, Barrett-Connor E, Reuben D et al (2006) Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen\/progestin interventions trial. J Women's Health 15(1):14\u201323","journal-title":"J Women's Health"},{"issue":"4","key":"1280_CR42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/gme.0b013e3181cc50b2","volume":"17","author":"R Karim","year":"2010","unstructured":"Karim R, Stanczyk FZ, Hodis HN, Cushman M, Lobo RA, Hwang J et al (2010) Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause (New York, NY) 17(4):785\u2013790","journal-title":"Menopause (New York, NY)"},{"issue":"2","key":"1280_CR43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.annepidem.2005.07.055","volume":"16","author":"HV Joffe","year":"2006","unstructured":"Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM (2006) Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol 16(2):105\u2013112","journal-title":"Ann Epidemiol"},{"issue":"8","key":"1280_CR44","first-page":"588","volume":"36","author":"N Guducu","year":"2013","unstructured":"Guducu N, Gormus U, Kutay SS, Kavak ZN, Telatar B (2013) Endogenous sex hormones and their associations with cardiovascular risk factors in post-menopausal women. J Endocrinol Invest 36(8):588\u2013592","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"1280_CR45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/oby.2002.150","volume":"10","author":"W-S Yang","year":"2002","unstructured":"Yang W-S, Lee W-J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C-L et al (2002) Plasma adiponectin levels in overweight and obese asians. Obes Res 10(11):1104\u20131110","journal-title":"Obes Res"},{"issue":"10","key":"1280_CR46","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772\u2013783","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1280_CR47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2006-1371","volume":"92","author":"AE Cust","year":"2007","unstructured":"Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A et al (2007) Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92(1):255\u2013263","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1280_CR48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.ijo.0803427","volume":"31","author":"GA Laughlin","year":"2006","unstructured":"Laughlin GA, Barrett-Connor E, May S (2006) Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes 31(3):457\u2013465","journal-title":"Int J Obes"},{"issue":"10","key":"1280_CR49","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","volume":"88","author":"A Gavrila","year":"2003","unstructured":"Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C et al (2003) Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88(10):4823\u20134831","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1280_CR50","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/oby.2007.263","volume":"15","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Mantzoros C, Hankinson SE (2007) Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity 15(9):2217\u20132224","journal-title":"Obesity"},{"issue":"3","key":"1280_CR51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/gme.0b013e31815c85ed","volume":"15","author":"Y Miyatani","year":"2008","unstructured":"Miyatani Y, Yasui T, Uemura H, Yamada M, Matsuzaki T, Kuwahara A et al (2008) Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 15(3):536\u2013541","journal-title":"Menopause"},{"issue":"12","key":"1280_CR52","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.metabol.2005.06.008","volume":"54","author":"L Sieminska","year":"2005","unstructured":"Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D et al (2005) Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 54(12):1610\u20131614","journal-title":"Metabolism"},{"issue":"5","key":"1280_CR53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/gme.0b013e31802cddca","volume":"14","author":"SC Hong","year":"2007","unstructured":"Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, Park YK et al (2007) Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 14(5):835\u2013840","journal-title":"Menopause"},{"issue":"4","key":"1280_CR54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11892-005-0023-2","volume":"5","author":"S Mazaki-Tovi","year":"2005","unstructured":"Mazaki-Tovi S, Kanety H, Sivan E (2005) Adiponectin and human pregnancy. Curr DiabRep 5(4):278\u2013281","journal-title":"Curr DiabRep"},{"issue":"9","key":"1280_CR55","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","volume":"18","author":"D Panidis","year":"2003","unstructured":"Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G (2003) Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 18(9):1790\u20131796","journal-title":"Hum Reprod"},{"issue":"11","key":"1280_CR56","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.metabol.2008.06.004","volume":"57","author":"A Kunnari","year":"2008","unstructured":"Kunnari A, Santaniemi M, Jokela M, Karjalainen AH, Heikkinen J, Ukkola O et al (2008) Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. Metabolism 57(11):1509\u20131515","journal-title":"Metabolism"},{"issue":"6","key":"1280_CR57","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.fertnstert.2006.04.043","volume":"86","author":"MC Chu","year":"2006","unstructured":"Chu MC, Cosper P, Nakhuda GS, Lobo RA (2006) A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 86(6):1669\u20131675","journal-title":"Fertil Steril"},{"issue":"10","key":"1280_CR58","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1161\/01.ATV.0000140198.16664.8e","volume":"24","author":"A Abbas","year":"2004","unstructured":"Abbas A, Fadel PJ, Wang Z, Arbique D, Jialal I, Vongpatanasin W (2004) Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler Thromb Vasc Biol 24(10):e164\u2013e167","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1280_CR59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","volume":"85","author":"S Vehkavaara","year":"2001","unstructured":"Vehkavaara S, Silveira A, Hakala-Ala-Pietil\u00e4 T, Virkam\u00e4ki A, Hovatta O, Hamsten A et al (2001) Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 85(4):619\u2013625","journal-title":"Thromb Haemost"},{"issue":"1","key":"1280_CR60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1189\/jlb.0210073","volume":"90","author":"V Douin-Echinard","year":"2011","unstructured":"Douin-Echinard V, Calippe B, Billon-Gales A, Fontaine C, Lenfant F, Tremollieres F et al (2011) Estradiol administration controls eosinophilia through estrogen receptor-alpha activation during acute peritoneal inflammation. J Leukoc Biol 90(1):145\u2013154","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1280_CR61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","volume":"43","author":"H Saeki","year":"2006","unstructured":"Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases. J Dermatol Sci 43(2):75\u201384","journal-title":"J Dermatol Sci"},{"issue":"5","key":"1280_CR62","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2003-10-3380","volume":"104","author":"\u00c5K Bengtsson","year":"2004","unstructured":"Bengtsson \u00c5K, Ryan EJ, Giordano D, Magaletti DM, Clark EA (2004) 17\u03b2-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104(5):1404\u20131410","journal-title":"Blood"},{"issue":"4","key":"1280_CR63","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2353\/ajpath.2006.060185","volume":"169","author":"CJ Lockwood","year":"2006","unstructured":"Lockwood CJ, Arcuri F, Toti P, Felice CD, Krikun G, Guller S et al (2006) Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 regulate interleukin-8 expression in third trimester decidual cells. Am J Pathol 169(4):1294\u20131302","journal-title":"Am J Pathol"},{"issue":"2","key":"1280_CR64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02247845","volume":"16","author":"NG Papadopoulos","year":"1997","unstructured":"Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP (1997) Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol 16(2):162\u2013165","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1280_CR65","first-page":"2032","volume":"86","author":"C Scheidt-Nave","year":"2001","unstructured":"Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R et al (2001) Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86(5):2032\u20132042","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1280_CR66","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.maturitas.2006.11.002","volume":"56","author":"T Yasui","year":"2007","unstructured":"Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H et al (2007) Changes in serum cytokine concentrations during the menopausal transition. Maturitas 56(4):396\u2013403","journal-title":"Maturitas"},{"issue":"2","key":"1280_CR67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000294853","volume":"33","author":"J Punnonen","year":"1992","unstructured":"Punnonen J, Heinonen PK, Teisala K, Kujansuu E, Jansen CT, Punnonen R (1992) Demonstration of tumor necrosis factor-\u03b1 in preovulatory follicular fluid: its association with serum 17\u03b2-estradiol and progesterone. Gynecol Obstet Invest 33(2):80\u201384","journal-title":"Gynecol Obstet Invest"},{"issue":"12","key":"1280_CR68","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/1055-9965.EPI-08-0311","volume":"17","author":"H-L Wong","year":"2008","unstructured":"Wong H-L, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS (2008) Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomark Prev 17(12):3450\u20133456","journal-title":"Cancer Epidemiol Biomark Prev"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-020-01280-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T21:34:39Z","timestamp":1614548079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-020-01280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s10552-020-01280-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}